Clinical Trials Logo

Keloid Scar Following Surgery clinical trials

View clinical trials related to Keloid Scar Following Surgery.

Filter by:
  • None
  • Page 1

NCT ID: NCT05461157 Enrolling by invitation - Wound Heal Clinical Trials

Preoperative Silicone Ointment and Wound Healing

Start date: November 14, 2022
Phase: N/A
Study type: Interventional

Optimal scar healing is of great importance to patients, especially following surgery of the head and neck. This study evaluates the effectiveness of preoperative silicone ointment in wound healing in head and neck surgeries.

NCT ID: NCT04951869 Completed - Clinical trials for Keloid Scar Following Surgery

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

Start date: April 26, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This study aimed to evaluate the effectiveness of Protescal in preventing post caesarean section hypertrophic scar and keloid formation.

NCT ID: NCT04710719 Completed - Keloid Clinical Trials

Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

There have been many modalities utilized in the treatment of keloids of the head and neck, however none have been universally successful. The most widely utilized non-surgical intervention is primary intralesional injection with triamcinolone (TAC) which inhibits the proliferation of fibroblasts, inhibits collagen synthesis, and increases collagenase production, or fluorouracil (5-FU), a potent inhibitor of fibroblast proliferation. Despite the abundance of studies evaluating primary intralesional injection for keloids, there are limited studies available regarding the efficacy of primary surgical excision followed by adjuvant intralesional injection. The proposed study herein would serve to improve the level of evidence and to establish the safety and efficacy of combined intralesional TAC+5FU for keloids following surgical excision.

NCT ID: NCT03876548 Withdrawn - Clinical trials for Keloid Scar Following Surgery

Initial Assessment of a Topical Cadexomer Iodine Gel Efficacy on Keloid Scar Revision

Start date: February 7, 2019
Phase: Early Phase 1
Study type: Interventional

This is a 6 month, single site, interventional, open label prospective clinical study to evaluate the effects of a cadexomer iodine gel on the prevention of recurrent keloid formation in patients undergoing keloid scar revision.